Close
AI in Healthcare & Pharma Summit Boston 2026

AI Drug Target Discovery Unmasks Neurodegenerative Diseases

Neurodegenerative diseases represent one of the most formidable medical and societal challenges of our time. Conditions like Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS), and...

AI Drug Discovery Fast-tracking Search for Cancer Treatment

The relentless pursuit of effective cancer treatments has long been a defining challenge in medical science. For decades, the arduous journey from a promising...

AI Drug Discovery Speeds Up Potential Cure for Rare Diseases

The landscape of medicine is constantly evolving, driven by an insatiable human desire to alleviate suffering and extend healthy lives. For too long, however,...

Insilico, Takeda Formalize AI Drug Discovery Partnership

In a significant move for the biotechnology sector, Insilico Medicine has finalized a global strategic collaboration with Takeda Pharmaceutical. This AI drug discovery partnership...

Anthropic Eyes Pharma Sector with Drug Discovery Expansion

Anthropic has taken another step in strengthening its position within life sciences research with the introduction of Claude Science, a new AI workbench designed...

Controlled Release Formulations Improving Drug Efficacy

The effectiveness of a medication is often limited not by its potency, but by the frequency and consistency of its administration. Modern developments in timed-release technology are optimizing how drugs are metabolized, maintaining steady therapeutic levels in the bloodstream and significantly enhancing the success rates of long-term treatments.

Water Quality Shapes the Future of Global Drug Development

The integrity of global drug development hinges on the consistent purity of water used throughout the research and manufacturing lifecycle. As therapies become more complex, the demand for precise water quality specifications grows, directly influencing the reliability of data and the speed of innovation in the pharmaceutical industry.

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...